跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

catalpol

首页药物catalpol

catalpol

未知生产厂商

生成 AI 研报

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

A PURIFIED EXTRACT ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM CONTAINING ABUNDANT AMOUNT OF ACTIVE INGREDIENT, THE PREPARATION THEREOF, AND THE COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING INFLAMMATION, ALLERGY AND ASTHMA
EP 2941263 B1申请人: YUNGJIN PHARMACEUTICAL CO LTD优先权: 2012
CN
EP
US
WO
8 件公开
Extract of Rehmannia glutinasa Libosch. for reducing blood glucose and lipid levels and treating hematologic diseases, and methods for preparing the same
US 9089595 B2申请人: ZHANG LING优先权: 2007
CN
EP
US
7 件公开
Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
- US 8168235 B2
  申请人: LEE HYEONG KYU优先权: 2005
  EP
  US
  WO
  6 件公开
- US 8455541 B2
  申请人: LEE HYEONG KYU优先权: 2012
  US
  2 件公开
- CN 101208084 B
  申请人: KOREA RES INST OF BIOSCIENCE优先权: 2006
  CN
Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient
US 9999646 B2申请人: YUNGJIN PHARMACEUTICAL CO LTD优先权: 2016
US
4 件公开
ATOMIZING LIQUID MODIFIER, ATOMIZING LIQUID AND AEROSOL GENERATING DEVICE
US 20260223911 A1申请人: SHENZHEN YUPENG TECH CO LTD优先权: 2023
CN
US
WO
3 件公开
Prescription and preparation method of catalpol injection and powder injection
CN 101919820 A申请人: UNIV SOUTHWEST优先权: 2009
CN
2 件公开
Formula of catalpol-puerarin injection and powder and preparation method
CN 101966196 A申请人: UNIV SOUTHWEST优先权: 2009
CN
2 件公开
THE COMPOSITION COMPRISING A PURIFIED EXTRACT ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM CONTAINING ABUNDANT AMOUNT OF ACTIVE INGREDIENT OR THE COMPOUNDS ISOLATED THEREFROM, AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE USE THEREOF
EP 3019182 B1申请人: YUNGJIN PHARMACEUTICAL CO LTD优先权: 2013
EP
2 件公开
Method of treating non-insulin dependent diabetes mellitus and related complications
- US 2005019435 A1
  申请人: YOUNG JEFFREY优先权: 2004
  US
- US 2010292178 A1
  申请人: YOUNG JEFFREY优先权: 2010
  US
Medical use of catalpol and its homologs
CN 1666992 A申请人: LUO HESHENG优先权: 2004
CN

第 1 / 9 页